Christine Earle

910 total citations
10 papers, 779 citations indexed

About

Christine Earle is a scholar working on Cell Biology, Oncology and Molecular Biology. According to data from OpenAlex, Christine Earle has authored 10 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cell Biology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Christine Earle's work include Proteoglycans and glycosaminoglycans research (6 papers), Fibroblast Growth Factor Research (3 papers) and MicroRNA in disease regulation (3 papers). Christine Earle is often cited by papers focused on Proteoglycans and glycosaminoglycans research (6 papers), Fibroblast Growth Factor Research (3 papers) and MicroRNA in disease regulation (3 papers). Christine Earle collaborates with scholars based in United States. Christine Earle's co-authors include Lilly Bourguignon, Gabriel Wong, Liqun Chen, Katherine C. Krueger, Christina C. Spevak, Marisa Shiina, Weiliang Xia, John K. Chan, Alexander E. Sherman and Kevin Blansit and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and International Journal of Molecular Sciences.

In The Last Decade

Christine Earle

10 papers receiving 773 citations

Peers

Christine Earle

ONCOL

IMMUN

Christina C. Spevak United States

Μαρίνα Κουτσιούμπα Greece

Jonathon D. Roybal United States

Catherine F. Welsh United States

Emilios Gemenetzidis United Kingdom

Roberto Sessa Italy

Alexandra Fullár Hungary

Shiro Kohi Japan

Raúl Peña Spain

Vanessa Bonazzi Australia

Christina C. Spevak United States

Christine Earle

640 ×1.2

294 ×1.0

262 ×1.0

ONCOL

199 ×0.7

50 ×0.9

IMMUN

Citations per year, relative to Christine Earle Christine Earle (= 1×) peers Christina C. Spevak

Countries citing papers authored by Christine Earle

Since Specialization

Citations

This map shows the geographic impact of Christine Earle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Earle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Earle more than expected).

Fields of papers citing papers by Christine Earle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Earle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Earle. The network helps show where Christine Earle may publish in the future.

Co-authorship network of co-authors of Christine Earle

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Earle. A scholar is included among the top collaborators of Christine Earle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Earle. Christine Earle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Bourguignon, Lilly, Christine Earle, & Marisa Shiina. (2018). Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance. Matrix Biology. 78-79. 180–200. 14 indexed citations

Bourguignon, Lilly, Christine Earle, & Marisa Shiina. (2017). Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. International Journal of Molecular Sciences. 18(9). 1849–1849. 68 indexed citations

Hurst, Robert E., Paul Hauser, Youngjae You, et al.. (2015). Identification of novel drugs to target dormant micrometastases. BMC Cancer. 15(1). 404–404. 11 indexed citations

Chan, John K., Kevin Blansit, T. Kiet, et al.. (2014). The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. Gynecologic Oncology. 132(3). 739–744. 123 indexed citations

Bourguignon, Lilly, Gabriel Wong, Christine Earle, & Liqun Chen. (2012). Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma. Journal of Biological Chemistry. 287(39). 32800–32824. 246 indexed citations

Wang, Steven J., Christine Earle, Gabriel Wong, & Lilly Bourguignon. (2012). Role of hyaluronan synthase 2 to promote CD44‐dependent oral cavity squamous cell carcinoma progression. Head & Neck. 35(4). 511–520. 22 indexed citations

Bourguignon, Lilly, Gabriel Wong, Christine Earle, & Weiliang Xia. (2011). Interaction of low molecular weight hyaluronan with CD44 and toll‐like receptors promotes the actin filament‐associated protein 110‐actin binding and MyD88‐NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton. 68(12). 671–693. 107 indexed citations

Bourguignon, Lilly, Gabriel Wong, Christine Earle, Katherine C. Krueger, & Christina C. Spevak. (2010). Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion. Journal of Biological Chemistry. 285(47). 36721–36735. 181 indexed citations

Enzinger, Peter C., Joseph I. Clark, David P. Ryan, et al.. (2004). Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer. Journal of Clinical Oncology. 22(14_suppl). 4040–4040. 1 indexed citations

10.

Enzinger, Peter C., Jeffrey W. Clark, David P. Ryan, et al.. (2004). Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer. Journal of Clinical Oncology. 22(14_suppl). 4040–4040. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact